Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2070-2020Class II

NRG RF Transseptal Kit; Model No.s : NTK-710-8545, NTK-710-8555, NTK-711-8545, NTK-711-8555, NTK-711-8590...

Baylis Medical Co., Inc. / initiated 2019-10-07 / Terminated / root cause: packaging

Baylis Medical Company Inc. began a recall of NRG RF Transseptal Kit; Model No.s : NTK-710-8545, NTK-710-8555, NTK-711-8545, NTK-711-8555, NTK-711-8590, NTK-P711-8545, NTK-P711-8555, NTK-710-8545S... on . FDA classified it as Class II and gives the reason as "There is a remote potential for the sterile packaging of the transseptal guiding sheath to be compromised during shipping and handling. In the case that a packaging defect is not identified and the product is used in a...". As of , the recall status on record is Terminated, and MDM tags the root cause as packaging.

Recall record

Recall number
Z-2070-2020
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Baylis Medical Co., Inc.
Product
NRG RF Transseptal Kit; Model No.s : NTK-710-8545, NTK-710-8555, NTK-711-8545, NTK-711-8555, NTK-711-8590, NTK-P711-8545, NTK-P711-8555, NTK-710-8545S, NTK-710-8555S, NTK-711-8545S, NTK-711-8555S, NTK-710-8545N, NTK-711-8545N and NTK-711-8555N.
Product code
DYB Introducer, Catheter
Reason for recall
There is a remote potential for the sterile packaging of the transseptal guiding sheath to be compromised during shipping and handling. In the case that a packaging defect is not identified and the product is used in a patient, there may be a remote risk of infection.
Root cause tag
packaging
FDA root cause
Package design/selection
Action
The firm sent Urgent Medical Device Recall Notification letters to customers via UPS and/or by email on 07-Oct-2019. The notifications were followed through by a tracking number to facilitate confirmation of package delivery. Customers were informed that all Torflex Transseptal Guiding Sheaths sold separately or as part of the NRG Transseptal kit are affected by this action. Customers were instructed to examine their stock, determine whether they had any of the affected lot numbers in stock, and if so, to quarantine affected product. Customers were requested to complete the acknowledgement form and return it to Baylis within 3 business days by email at [email protected] or by faxing the completed form to 906-602-5671 Attn: Quality Department. Customers were informed that once the completed Acknowledgement form was received by Baylis, they would be contacted by a Baylis Medical Representative within 5 business days to manage the disposition of any identified quarantined product. Customers were instructed to address specific questions regarding the recall to Mrs. Ellen Harfield, Director of Quality at 1-800-276-4416.
Quantity in commerce
Total of 59067 units (includes both individual units and those sold in NRG RF Transseptal Kits).
Distribution
Product distributed throughout the 50 states and in Washington D.C.
Product codes and lots
All lot numbers of the following kit model numbers: NTK-710-8545, NTK-710-8555, NTK-711-8545, NTK-711-8555, NTK-711-8590, NTK-P711-8545, NTK-P711-8555, NTK-710-8545S, NTK-710-8555S, NTK-711-8545S, NTK-711-8555S, NTK-710-8545N, NTK-711-8545N, and NTK-711-8555N.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2070-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2069-2020Class IITerminatedVoluntary: Firm initiated
Z-2070-2020Class IITerminatedVoluntary: Firm initiated